C-RAD AB UPPSALA B 

$4.2
2
+$0+0% Thursday 15:32

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
138.21M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

18JulExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.02
0
0.03
0.05
Expected EPS
0.053601
Actual EPS
N/A

Financials

12.07%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
75.61MRevenue
9.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRADF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating; and Sentinel 4DCT, a laser-based optical surface scanning system. It also provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst PT, a tracking solution for particle therapy; and visual coaching solutions used for prospective and retrospective radiotherapy. In addition, the company offers cAutoVerify, an automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking; and cAccessory, which automates the registration and validation of treatment accessories. Further, it provides SmartPhantom RT, a device that allows automatic adjustment and alignment of fixed lasers with motorization; StaticPhantom, a set-up used to visually verify the precision of the alignment of lasers; high impact technology motorized system, a laser positioning system; HIT Single Diode; and HIT1, HIT3, and HIT5 patient positioning laser, as well as laser positioning products and solutions. Additionally, the company offers support and training services; and service contracts. C-Rad AB (publ) was incorporated in 2004 and is headquartered in Uppsala, Sweden.
Show more...
CEO
Mr. Tomas Blomquist
Employees
110
Country
SE

Listings

0 Comments

Share your thoughts

FAQ

What is C-RAD AB UPPSALA B stock price today?
The current price of CRADF is $4.2 USD — it has increased by +0% in the past 24 hours. Watch C-RAD AB UPPSALA B stock price performance more closely on the chart.
What is C-RAD AB UPPSALA B stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange C-RAD AB UPPSALA B stocks are traded under the ticker CRADF.
What is C-RAD AB UPPSALA B market cap?
Today C-RAD AB UPPSALA B has the market capitalization of 138.21M
What is C-RAD AB UPPSALA B revenue for the last year?
C-RAD AB UPPSALA B revenue for the last year amounts to 75.61M USD.
What is C-RAD AB UPPSALA B net income for the last year?
CRADF net income for the last year is 9.13M USD.
How many employees does C-RAD AB UPPSALA B have?
As of April 08, 2026, the company has 110 employees.
In which sector is C-RAD AB UPPSALA B located?
C-RAD AB UPPSALA B operates in the Health Care sector.
When did C-RAD AB UPPSALA B complete a stock split?
C-RAD AB UPPSALA B has not had any recent stock splits.
Where is C-RAD AB UPPSALA B headquartered?
C-RAD AB UPPSALA B is headquartered in Uppsala, SE.